Infections in solid-organ transplant recipients

R Patel, CV Paya - Clinical microbiology reviews, 1997 - Am Soc Microbiol
Solid-organ transplantation is a therapeutic option for many human diseases. Infections are
a major complication of solid-organ transplantation. All candidates should undergo a …

[HTML][HTML] Aciclovir: a reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy

AJ Wagstaff, D Faulds, KL Goa - Drugs, 1994 - Springer
Aciclovir (acyclovir) is a nucleoside analogue with antiviral activity in vitro against the herpes
simplex viruses (HSV), varicella zoster virus (VZV), Epstein-Barr virus (EBV) …

Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients

E Gane, F Saliba, GJC Valdecasas, J O'Grady… - The Lancet, 1997 - thelancet.com
Background Cytomegalovirus (CMV) disease is a frequent cause of serious morbidity after
solid-organ transplantation. The prophylactic regimens used to prevent CMV infection and …

Esophageal infections: risk factors, presentation, diagnosis, and treatment

PH Baehr, GB McDonald - Gastroenterology, 1994 - Elsevier
Infections of the esophagus are unusual in the general population and strongly imply
immunodeficiency, although immunocompetent individuals are not exempt. HIV infection is …

Infection in the organ transplant recipient

RH Rubin - Clinical approach to infection in the compromised host, 2002 - Springer
Over the past 30 years, organ transplantation has been transformed from an interesting
experiment in human immunobiology to the most practical means of rehabilitating patients …

Cytomegalovirus immune globulin prophylaxis in liver transplantation: a randomized, double-blind, placebo-controlled trial

DR Snydman, BG Werner, NN Dougherty… - Annals of internal …, 1993 - acpjournals.org
Objective: To study the effect of cytomegalovirus immune globulin (CMVIG) on prevention of
cytomegalovirus (CMV) disease and its complications in patients receiving liver transplants …

Cytomegalovirus infection following liver transplantation: review of the literature

SS Kanj, AI Sharara, PA Clavien… - Clinical infectious …, 1996 - academic.oup.com
Cytomegalovirus (CMV) remains a major cause of problems following solid organ
transplantation, accounting for a significant increase in morbidity and affiliated costs …

Clinical outcomes of polyvalent immunoglobulin use in solid organ transplant recipients: A systematic review and meta‐analysis

S Bourassa‐Blanchette, GA Knoll, B Hutton… - Clinical …, 2019 - Wiley Online Library
Polyvalent immunoglobulin is commonly used for desensitization and treatment of antibody‐
mediated rejection in kidney transplantation but its impact on other outcomes is not known …

A randomized prospective trial of acyclovir and immune globulin prophylaxis in liver transplant recipients receiving OKT3 therapy

RJ Stratta, MS Shaefer, KA Cushing… - Archives of …, 1992 - jamanetwork.com
• The use of OKT3 therapy is a major risk factor for opportunistic infections in liver transplant
recipients. In the last 2 years, we prospectively randomized 100 patients receiving OKT3 …

Current status of liver transplantation in children

SV McDiarmid - Pediatric Clinics, 2003 - pediatric.theclinics.com
Liver transplantation for children with life-threatening acute or chronic liver disease has
proven within two decades to have durable and high success rates [1–3]. Thousands of …